ATE271875T1 - USE OF KETOLIDES FOR PREVENTING THROMBOTIC COMPLICATIONS ASSOCIATED WITH ATHEROSCLERosis - Google Patents

USE OF KETOLIDES FOR PREVENTING THROMBOTIC COMPLICATIONS ASSOCIATED WITH ATHEROSCLERosis

Info

Publication number
ATE271875T1
ATE271875T1 AT98955662T AT98955662T ATE271875T1 AT E271875 T1 ATE271875 T1 AT E271875T1 AT 98955662 T AT98955662 T AT 98955662T AT 98955662 T AT98955662 T AT 98955662T AT E271875 T1 ATE271875 T1 AT E271875T1
Authority
AT
Austria
Prior art keywords
ketolides
atherosclerosis
complications associated
thrombotic complications
preventing thrombotic
Prior art date
Application number
AT98955662T
Other languages
German (de)
Inventor
Francis Petit
Francoise Vacheron
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE271875T1 publication Critical patent/ATE271875T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT98955662T 1997-11-17 1998-11-16 USE OF KETOLIDES FOR PREVENTING THROMBOTIC COMPLICATIONS ASSOCIATED WITH ATHEROSCLERosis ATE271875T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714358A FR2771008B1 (en) 1997-11-17 1997-11-17 USE OF KETOLIDES FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR PREVENTING ARTERIAL THROMBOTIC COMPLICATIONS LINKED TO ATHEROSCLEROSIS
PCT/FR1998/002436 WO1999025365A1 (en) 1997-11-17 1998-11-16 Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis

Publications (1)

Publication Number Publication Date
ATE271875T1 true ATE271875T1 (en) 2004-08-15

Family

ID=9513423

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98955662T ATE271875T1 (en) 1997-11-17 1998-11-16 USE OF KETOLIDES FOR PREVENTING THROMBOTIC COMPLICATIONS ASSOCIATED WITH ATHEROSCLERosis

Country Status (35)

Country Link
US (1) US20080139489A1 (en)
EP (1) EP1030673B1 (en)
JP (1) JP4550273B2 (en)
KR (1) KR20010032130A (en)
CN (1) CN1286633A (en)
AP (1) AP1196A (en)
AR (1) AR014119A1 (en)
AT (1) ATE271875T1 (en)
AU (1) AU744419B2 (en)
BG (1) BG104427A (en)
BR (1) BR9814199A (en)
CA (1) CA2312021C (en)
DE (1) DE69825308T2 (en)
DZ (1) DZ2654A1 (en)
EA (1) EA003322B1 (en)
EE (1) EE04095B1 (en)
ES (1) ES2224446T3 (en)
FR (1) FR2771008B1 (en)
GE (1) GEP20032968B (en)
HR (1) HRP20000314A2 (en)
HU (1) HUP0004507A3 (en)
ID (1) ID24940A (en)
IL (1) IL136149A0 (en)
MA (1) MA26566A1 (en)
NO (1) NO20002435L (en)
NZ (1) NZ504305A (en)
OA (1) OA11411A (en)
PL (1) PL340373A1 (en)
SK (1) SK7042000A3 (en)
TN (1) TNSN98206A1 (en)
TR (1) TR200001384T2 (en)
TW (1) TW472061B (en)
WO (1) WO1999025365A1 (en)
YU (1) YU29600A (en)
ZA (1) ZA9810357B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2777282B1 (en) * 1998-04-08 2001-04-20 Hoechst Marion Roussel Inc NEW DERIVATIVES OF 2-FLUORO 3-DE ((2,6-DIDEOXY 3-C-METHYL 3-0-METHYL-ALPHA-L-RIBOHEXOPYRANOSYL) OXYL) 6-O-METHYL 3-OXO ERYTHROMYCIN, THEIR PREPARATION PROCESS AND THEIR APPLICATION TO THE SYNTHESIS OF ACTIVE INGREDIENTS OF MEDICINES
DE69933897T2 (en) 1998-12-10 2007-03-15 Pfizer Products Inc., Groton Carbamate and carbazate ketolide antibiotics
CA2359708C (en) * 1999-01-27 2005-10-25 Pfizer Products Inc. Ketolide antibiotics
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
DE60139382D1 (en) 2000-04-04 2009-09-10 Smithkline Beecham Plc 2-HYDROXY-MUTILINE-CARBAMATE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS
JP2004323414A (en) * 2003-04-24 2004-11-18 Japan Science & Technology Agency A therapeutic agent for a disease caused by proliferation of vascular smooth muscle using a 14-membered ring macrolide compound
GB0402578D0 (en) * 2004-02-05 2004-03-10 Cambridge Theranostics Ltd Methods of treatment of atherosclerosis
EP2613630A4 (en) * 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc FLUOROCETOLIDES FORMING HYDROGEN LINKS TO TREAT DISEASES

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5424187A (en) * 1991-06-14 1995-06-13 Board Of Regents Of The University Of Washington Method of screening for arterial chlamydial granuloma
FR2718450B1 (en) * 1994-04-08 1997-01-10 Roussel Uclaf New erythromycin derivatives, their preparation process and their use as drugs.
FR2719587B1 (en) * 1994-05-03 1996-07-12 Roussel Uclaf New erythromycin derivatives, their preparation process and their use as drugs.
FR2742757B1 (en) * 1995-12-22 1998-01-30 Roussel Uclaf NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
US6271255B1 (en) * 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
GB9621771D0 (en) * 1996-10-18 1996-12-11 St George S Enterprises Ltd Method of treatment of heart disease
FR2757168B1 (en) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics

Also Published As

Publication number Publication date
AP2000001825A0 (en) 2000-06-30
TNSN98206A1 (en) 2005-03-15
OA11411A (en) 2004-04-20
NO20002435D0 (en) 2000-05-11
AU1242599A (en) 1999-06-07
HUP0004507A3 (en) 2001-12-28
DE69825308T2 (en) 2005-08-04
EE200000244A (en) 2001-06-15
HUP0004507A1 (en) 2001-05-28
GEP20032968B (en) 2003-05-27
FR2771008A1 (en) 1999-05-21
EA003322B1 (en) 2003-04-24
NZ504305A (en) 2002-11-26
SK7042000A3 (en) 2000-12-11
BR9814199A (en) 2000-09-26
JP2001523644A (en) 2001-11-27
CN1286633A (en) 2001-03-07
EA200000531A1 (en) 2000-10-30
EE04095B1 (en) 2003-08-15
TW472061B (en) 2002-01-11
FR2771008B1 (en) 2000-04-28
HRP20000314A2 (en) 2001-02-28
EP1030673B1 (en) 2004-07-28
TR200001384T2 (en) 2001-06-21
IL136149A0 (en) 2001-05-20
CA2312021C (en) 2008-08-26
DZ2654A1 (en) 2003-03-22
CA2312021A1 (en) 1999-05-27
AP1196A (en) 2003-08-18
DE69825308D1 (en) 2004-09-02
WO1999025365A1 (en) 1999-05-27
US20080139489A1 (en) 2008-06-12
PL340373A1 (en) 2001-01-29
ID24940A (en) 2000-08-31
NO20002435L (en) 2000-07-07
YU29600A (en) 2003-02-28
ZA9810357B (en) 1999-11-12
KR20010032130A (en) 2001-04-16
AU744419B2 (en) 2002-02-21
AR014119A1 (en) 2001-02-07
ES2224446T3 (en) 2005-03-01
EP1030673A1 (en) 2000-08-30
JP4550273B2 (en) 2010-09-22
MA26566A1 (en) 2004-12-20
BG104427A (en) 2001-02-28

Similar Documents

Publication Publication Date Title
ATE233241T1 (en) STABLE REAGENTS FOR THE PRODUCTION OF RADIOPHARMACEUTICS
DE69414543D1 (en) Use of foam control compositions
DE69735359D1 (en) SYSTEM FOR SELECTION OF PRODUCTS
DE69427029D1 (en) ENGINE CONTROL METHOD
DE69804506D1 (en) METHOD FOR PRODUCING HYDROXYAPATITE SUBSTITUTED WITH CARBONATE AND MAGNESIUM
ATE291897T1 (en) USE OF COMPOSITIONS CONTAINING STABILIZED ENZYMES
DE69913030D1 (en) Combustion control method
DE69717038D1 (en) Glass panels for the production of glazing
DE69813278T2 (en) CALCIUM COMPLEX FOR STRENGTHENING FOODSTUFFS
ID26161A (en) POLYESTER FIBER AND METHOD TO MAKE IT
EP1082402A4 (en) METHOD FOR THE PRODUCTION OF FUELS WITH HIGH LUBRICABILITY AND LOW SULFUR CONTENT
DE69414404D1 (en) Bioluminescence control method
DE69811802D1 (en) Transesterification process
DE69710479D1 (en) ORGANOMINERAL GEL FOR THE DECONTAMINATION OF SURFACES
DE69612888D1 (en) Techniques for controlling remote lamp loads
DE69511878D1 (en) METHOD FOR THE WET DESULFURATION OF SMOKE GASES WITH LIMESTONE
DE59708157D1 (en) System for determining the shape and color structure of teeth
DE59710206D1 (en) Process for the polycondensation of polyester
DE69721994D1 (en) SYSTEM FOR FIXING PANEL-SHAPED MATERIAL
DE69529343D1 (en) METHOD FOR INSULATING MESOPHASEPECH
DE59802737D1 (en) METHOD FOR THE CONTINUOUS PRODUCTION OF DIHYDROXYDIARYLALKANES
ATE271875T1 (en) USE OF KETOLIDES FOR PREVENTING THROMBOTIC COMPLICATIONS ASSOCIATED WITH ATHEROSCLERosis
DE59507418D1 (en) Process for the control of polycondensation or polyaddition reactions
DE69515179D1 (en) COMPONENT FOR ESTABLISHING STRUCTURES
ATE223887T1 (en) METHOD FOR THE TRANSESTERIFICATION OF ALPHA-KETOCARBOXYLIC ACIDS

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties